Showing results (1931-1940 of 4,056) with videos related to

Sort By:
Pageof 406
Translational Cancer Research|August 13, 2026
Development and validation of a multivariable CT-based Delta-radiomics model for predicting efficacy to bevacizumab therapy in patients with colorectal liver metastasesLong Yuan, Shenglin Li, Yuntai Cao, et al.
Translational Cancer Research|August 13, 2026
Construction of lactate-myeloid-related prognostic risk model and prediction of immune-excluded microenvironment in gastric cancer via integrated scRNA-Seq and bulk RNA-SeqXiaying Han, Qimiao Chen, Xijian Huang, et al.
Translational Cancer Research|August 13, 2026
Clinicopathological characteristics and prognosis of breast carcinoma with apocrine differentiation: a propensity score-matched analysis of the SEER databaseManxiu Li, Liting Jin, Jun Shao, et al.
Translational Cancer Research|August 13, 2026
Sequential HER2-targeted antibody-drug conjugate therapy for acquired resistance in a 55-year-old male kidney transplant recipient with metastatic urothelial carcinoma: a case reportTianying Li, Yinuo Zhang, Genkun Liu, et al.
Translational Cancer Research|August 13, 2026
Palmitoylation-related gene signature for immune subtyping, prognostic stratification, and immunotherapy guidance in hepatocellular carcinomaXiang Gao, Fangzhou Wang, Yuanxu Qu, et al.
Translational Cancer Research|August 13, 2026
PLAU accelerates extracellular matrix remodeling through partial epithelial-mesenchymal transition in head and neck squamous cell carcinomaZhichang Liu, Qiaojing Jia, Zhichao Yang, et al.
Translational Cancer Research|August 13, 2026
miR-506-5p targets MAPK7 to impede glioma growth and invasion through suppressing epithelial-mesenchymal transition and matrix metalloproteinasesTingting Sun, Guojin Wang, Ye Chen, et al.
Translational Cancer Research|August 13, 2026
Interpretable machine learning prediction of 1-year overall survival in pancreatic cancer patients aged 65 years and olderBo Zeng, Hongyi Liu, Qi Huang
Translational Cancer Research|August 13, 2026
TRIM47 promotes cell viability, cell cycle progression, metabolic reprogramming, and inhibits apoptosis of glioma via the NF-κB signaling pathwayXin Lai, Jin Zhu, Haocheng Jia, et al.
Translational Cancer Research|August 13, 2026
A radiotherapy resistance-related prognostic signature predicts survival and the immune landscape in rectal cancerTingting Jiang, Liyuan Zhu, Rujin Jiang, et al.
Pageof 406